Evidence map›Paper›PMID 42472708›Full record

ArticleScientific reports2026

Combined impact of recent sexual activity and vaginal product use on genital immune activation in South African women: implications for HIV risk.

Samukelisiwe Radebe, Phumla Radebe, Zanenhlanhla Gumbi, Ramla F Tanko, Monalisa Manhanzva, Ntombenhle Mntambo, Hilton Humphries, Natasha Samsunder, Lara Lewis, Marothi Letsoalo and 11 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Samukelisiwe RadebeCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Phumla RadebeSchool of Life Sciences in the College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Carbis Road, Pietermaritzburg, 3209, South Africa.
Zanenhlanhla GumbiCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Ramla F TankoInstitute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa.
Monalisa ManhanzvaInstitute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa.
Ntombenhle MntamboCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Hilton HumphriesCentre for Community-Based Research, Human Science Research Council, Pietermaritzburg, South Africa.
Natasha SamsunderCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Lara LewisCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Marothi LetsoaloCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Andile MtshaliCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Gugulethu MzobeCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Disebo PotloaneCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Lindi MassonCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Jo-Ann S PassmoreCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Heather B JaspanInstitute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa.
Bester SarucheraSchool of Mathematics, Statistics and Computer Science in the College of Agriculture, Engineering and Science University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Quarraisha Abdool KarimCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Sinaye NgcapuCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
Rubina BunjunInstitute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa.
Pamela P MkhizeCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa. Mkhizep6@ukzn.ac.za.

Funding

National Institute of Health R01A1128792
6 · The paper itself

Abstract

Adolescent girls and young women (AGYW) in South Africa experience a disproportionate burden of HIV infection. Genital inflammation has been implicated in increased HIV susceptibility through enhanced availability of target immune cells; however, the effects of recent sexual activity and vaginal-stimulating product (VSP) use on mucosal immune responses remain incompletely defined. This study characterised mucosal immune profiles following recent sexual exposure and VSP use in adolescent and adult women. HIV-negative sexually active adolescents (14-19 years) and adult women (25-35 years) were enrolled in a longitudinal cohort in KwaZulu-Natal, South Africa. Cervical cytobrush samples and cervicovaginal secretions were collected at baseline (≥ 2 weeks abstinence) and following reported sexual activity and/or VSP use. Cervical T-cell activation markers (CD38, HLA-DR, CCR5, α4β7) were quantified by flow cytometry, and 18 cytokines and chemokines were measured using a multiplex assay. Associations with time since last sexual intercourse were assessed using correlation analyses, and factors associated with genital inflammation were evaluated using weighted logistic regression. Recent sexual activity showed inverse associations with several pro-inflammatory cytokines, including MIP-1α, IL-1α, IL-1β, GM-CSF, and IL-17, consistent with a transient pattern of mucosal immune activation following exposure. In multivariable models, recent sexual activity (OR 0.58; p = 0.009) and bacterial vaginosis (OR 2.38; p = 0.017) were independently associated with genital inflammation, whereas VSP use was not statistically significant after adjustment (OR 1.63; p = 0.187). Although higher cytokine concentrations were observed among VSP users in unadjusted analyses, including IL-1α in adolescents (p = 0.001) and MIP-1α in adults (p = 0.017), these associations did not remain significant after correction for multiple testing. Overall, these findings suggest that recent sexual activity is associated with transient changes in mucosal immune mediators, while VSP use does not independently predict genital inflammation in this cohort after adjustment for confounding and multiple testing. These results highlight the importance of timing of exposure in interpreting mucosal immune measurements and support further longitudinal studies with precise sampling intervals to better define post-coital immune dynamics and the role of behavioural practices in shaping genital immunity.

Indexed as

HIVimmune activationrecent sexual activityvaginal stimulating productswomen

Identifiers

PMID42472708
PMCPMC13680280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.